Statins Moderate Effect of Metformin on Prostate Cancer

This article originally appeared here.
Share this content:
Statins Moderate Effect of Metformin on Prostate Cancer
Statins Moderate Effect of Metformin on Prostate Cancer

(HealthDay News) – For men with type 2 diabetes treated with metformin, prostate cancer (PCa) incidence varies depending on statin use, with a significantly reduced risk for patients taking a combination of metformin and statins, according to a study published online March 28 in Diabetes Care.

Donna M. Lehman, PhD, from the University of Texas Health Science Center in San Antonio, and colleagues analyzed data from 5,042 men with type 2 diabetes treated in the Veteran Administration Health Care System. Participants had no history of prior cancer and were treated exclusively with metformin or sulfonylurea as a hypoglycemic medication between 1999 and 2005.

During a mean follow-up of five years, the researchers found that 7.5% of men had a PCa diagnosis. Metformin correlated with a significantly lower PCa incidence among patients on statins (hazard ratio [HR], 0.69; 17 cases in 533 metformin users vs. 135 cases in 2,404 sulfonylureas users) and an elevated PCa incidence among patients not on statins (HR, 2.15; 22 cases in 175 metformin users vs. 186 cases in 1,930 sulfonylureas users). When compared with those patients taking neither medication, patients treated with metformin and statins had a PCa incidence HR of 0.32.

"Among men with type 2 diabetes, PCa incidence among metformin users varied by their statin use," the authors write. "The potential beneficial influence on PCa by combination use of metformin and statin may be due to synergistic effects."

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs